JIT Inventory Risk

JIT Inventory Risk refers to the vulnerability created when minimal inventory levels are maintained under just-in-time supply strategies, increasing exposure to supplier delays, transport disruptions, and demand fluctuations. In critical industries such as pharmaceuticals, shortages can directly impact patient care and regulatory commitments. This risk becomes particularly significant for single-source raw materials or cold chain-dependent components.

The pharmaceutical industry addresses JIT inventory risk through risk-based inventory planning, dual sourcing, supplier qualification, and contingency strategies. Critical raw materials such as resins, filters, and sterile components may require safety stock despite JIT efficiency goals. Supply chain teams evaluate lead times, geopolitical risks, and quality variability when setting inventory targets. Regulatory expectations for supply continuity further emphasise resilience planning. As global disruptions increase and supply chains become more complex, balancing efficiency with risk mitigation remains a key operational priority for maintaining continuous patient supply.